{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T05:33:53Z","timestamp":1792128833942,"version":"4.4.0"},"reference-count":76,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,19]],"date-time":"2013-03-19T00:00:00Z","timestamp":1363651200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0058607","type":"journal-article","created":{"date-parts":[[2013,3,19]],"date-time":"2013-03-19T21:07:20Z","timestamp":1363727240000},"page":"e58607","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Development of Antipsychotic Medications with Novel Mechanisms of Action Based on Computational Modeling of Hippocampal Neuropathology"],"prefix":"10.1371","volume":"8","author":[{"given":"Peter J.","family":"Siekmeier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"vanMaanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,3,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.31887\/DCNS.2010.12.3\/sstilo","article-title":"The epidemiology of schizophrenia: replacing dogma with knowlege","volume":"12","author":"SA Stilo","year":"2010","journal-title":"Dialogues in Clinical Neuroscience"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.62.1.19","article-title":"Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis","volume":"62","author":"DC Henderson","year":"2005","journal-title":"Archives of General Psychiatry"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"359382","DOI":"10.31887\/DCNS.2010.12.3\/jcoyle","article-title":"Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia","volume":"12","author":"JT Coyle","year":"2010","journal-title":"Dialogues in Clinical Neuroscience"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/7854_2010_43","article-title":"Hippocampal pathology in schizophrenia","volume":"4","author":"S Heckers","year":"2010","journal-title":"Current Topics in Behavioral Neurosciences"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0893-133X(01)00225-1","article-title":"GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder","volume":"25","author":"F Benes","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"ref6","first-page":"365","article-title":"Glutamate and schizophrenia: beyond the dopamine hypothesis","volume":"4\u20136","author":"J Coyle","year":"2006","journal-title":"Cellular and Molecular Neurobiology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/hipo.1072","article-title":"Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia","volume":"11","author":"R Greene","year":"2001","journal-title":"Hippocampus"},{"key":"ref8","unstructured":"Hoffman RE, McGlashan TH (2003) Schizophrenia: From psychodynamic to neurodynamic theories. In: Sadock JS, Sadock VA, editors. Kaplan and Sadock&apos;s Synopsis of Psychiatry. 9th ed. Philadelphia, PA: Lippincott Williams and Wilkins."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0022-3956(82)90038-3","article-title":"Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?","volume":"17","author":"I Feinberg","year":"1982","journal-title":"Journal of Psychiatric Research"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1098\/rsta.2007.2092","article-title":"The criticality hypothesis: how local cortical networks might optimize information processing","volume":"366","author":"J Beggs","year":"2008","journal-title":"Philosophical Transactions of the Royal Society A: Physical, Mathematical and Engineering Sciences"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.conb.2011.10.018","article-title":"Excitation, inhibition, local oscillations, or large-scale loops: what causes the symptoms of schizophrenia?","volume":"22","author":"J Lisman","year":"2012","journal-title":"Current Opinion in Neurobiology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"19878","DOI":"10.1073\/pnas.0609440103","article-title":"Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia","volume":"103","author":"RY Cho","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1176\/appi.ajp.2008.07111733","article-title":"Reduced evoked gamma oscillations in the frontal cortex in schizophrenia patients: a TMS\/EEG study","volume":"165","author":"F Ferrarelli","year":"2008","journal-title":"American Journal of Psychiatry"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1523\/JNEUROSCI.5031-07.2008","article-title":"Abnormal neural oscillatory activity to speech sounds in schizophrenia: a magnetoencephalography study","volume":"28","author":"S Hirano","year":"2008","journal-title":"Journal of Neuroscience"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biopsych.2008.02.021","article-title":"Gamma-band auditory steady-state responses are imparied in first episode psychosis","volume":"64","author":"KM Spencer","year":"2008","journal-title":"Biological Psychiatry"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.neuroimage.2008.06.020","article-title":"Cortical source estimates of gamma band amplitude and phase are different in schizophrenia","volume":"42","author":"P Teale","year":"2008","journal-title":"Neuroimage"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.biopsych.2006.03.055","article-title":"Gamma band oscillations reveal neural network cortical coherence dysfunction in schizophrenia patients","volume":"60","author":"GA Light","year":"2006","journal-title":"Biological Psychiatry"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1073\/pnas.97.4.1867","article-title":"Gamma rhythms and beta rhythms have different synchronization properties","volume":"97","author":"N Kopell","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1055\/s-2006-931501","article-title":"Toward a prefrontal microcircuit model for cognitive deficits in schizophrenia","volume":"39","author":"X Wang","year":"2006","journal-title":"Pharmacopsychiatry"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.biopsych.2008.05.015","article-title":"The dual-state theory of prefrontal cortex dopamine function wiht relevance to catechol-o-methyltransferase genotypes and schizophrenia","volume":"64","author":"D Durstewitz","year":"2008","journal-title":"Biological Psychiatry"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1001\/archpsyc.1987.01800140090014","article-title":"Computer simulations of neural information processing and the schizophrenia-mania dichotomy","volume":"44","author":"RE Hoffman","year":"1987","journal-title":"Archives of General Psychiatry"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nrn2462","article-title":"Computational models of schizophrenia and dopamine modulation in the prefrontal cortex","volume":"9","author":"ET Rolls","year":"2008","journal-title":"Nature Reviews Neuroscience"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.schres.2006.08.007","article-title":"Modeling of context-dependent retrieval in hippocampal region CA1: Implications for cognitive function in schizophrenia","volume":"89","author":"PJ Siekmeier","year":"2007","journal-title":"Schizophrenia Research"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1113\/jphysiol.1994.sp020420","article-title":"A branching dendritic model of a rodent CA3 pyramidal neurone","volume":"481","author":"RD Traub","year":"1994","journal-title":"Journal of Physiology (London)"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF00961441","article-title":"Pyramidal cell-to-inhibitory cell spike transduction explicable by active dendritic conductances in inhibitory cell","volume":"2","author":"RD Traub","year":"1995","journal-title":"Journal of Computational Neuroscience"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbr.2009.01.021","article-title":"Evidence of multistability in a realistic computer simulation of hippocampus subfield CA1","volume":"200","author":"PJ Siekmeier","year":"2009","journal-title":"Behavioural Brain Research"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/archpsyc.1995.03950220039008","article-title":"Abnormal excitatory neurotransmitter metabolism in schizophrenic brains","volume":"52","author":"G Tsai","year":"1995","journal-title":"Archives of General Psychiatry"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/sj.npp.1300559","article-title":"NAAG reduces NMDA receptor current in CA1 hippocampal pyramidal neurons of acute slices and dissociated neurons","volume":"30","author":"T Bergeron","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"ref29","first-page":"2971","article-title":"Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses","volume":"12","author":"A Law","year":"2001","journal-title":"Neurochemistry"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1196\/annals.1300.006","article-title":"Glutamate receptors and transporters in the hippocampus in schizophrenia","volume":"1003","author":"P Harrison","year":"2003","journal-title":"Annals of the New York Academy of Sciences"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/schbul\/15.3.477","article-title":"Cortical pruning and the development of schizophrenia: a computer model","volume":"15","author":"RE Hoffman","year":"1989","journal-title":"Schizophrenia Bulletin"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1176\/ajp.161.10.1848","article-title":"Reduced spinophilin but not microtubule-associated protein 2 express in the hippocampal formation in schizohprenia and mood disorders: Molecular evidence for a pathology of dendritic spines","volume":"161","author":"A Law","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/jnnp.65.4.446","article-title":"Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia","volume":"65","author":"LJ Garey","year":"1998","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1601-183X.2010.00656.x","article-title":"Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology","volume":"10","author":"L Devito","year":"2011","journal-title":"Genes Brain Behav"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archpsyc.59.6.521","article-title":"Differential Hippocampal Expression of Glutamic Acid Decarboxylase 65 and 67 Messenger RNA in Bipolar Disorder and Schizophrenia","volume":"59","author":"S Heckers","year":"2002","journal-title":"Archives of General Psychiatry"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0140-6736(77)91542-2","article-title":"Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses","volume":"2","author":"E Bird","year":"1977","journal-title":"The Lancet"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/sj.mp.4000783","article-title":"Reduction in reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression","volume":"5","author":"S Fatemi","year":"2000","journal-title":"Molecular Psychiatry"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.biopsych.2004.10.019","article-title":"Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains","volume":"57","author":"E Torrey","year":"2005","journal-title":"Biological Psychitry"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/(SICI)1098-2396(199604)22:4<338::AID-SYN5>3.0.CO;2-C","article-title":"Differences in the subregional and cellular distribution of GABA<sub>A<\/sub> receptor binding in the hippocampal formation of schizophrenic brain","volume":"22","author":"FM Benes","year":"1996","journal-title":"Synapse"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tins.2008.02.005","article-title":"Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia","volume":"31","author":"J Lisman","year":"2008","journal-title":"Trends in Neuroscience"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/archpsyc.56.11.1001","article-title":"Gamma frequency-range abnormalities to auditory stimulation in schizophrenia","volume":"56","author":"JS Kwon","year":"1999","journal-title":"Archives of General Psychiatry"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0026-895X(25)10553-1","article-title":"Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors","volume":"48","author":"TH Johansen","year":"1995","journal-title":"Mol Pharmacol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1124\/mol.58.4.802","article-title":"Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466","volume":"58","author":"AC Arai","year":"2000","journal-title":"Mol Pharmacol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1124\/jpet.102.040360","article-title":"Benzamide-type AMPA receptor modulators form two subfamilies with distinct modes of action","volume":"303","author":"AC Arai","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/jpet.109.157909","article-title":"Benzodiazepine binding site occupancy by the novel GABAA receptor subtype-selective drug 7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,4-b]pyridazine (TPA023) in rats, primates, and humans","volume":"332","author":"JR Atack","year":"2010","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1176\/appi.ajp.2008.08030395","article-title":"Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia","volume":"165","author":"DA Lewis","year":"2008","journal-title":"American Journal of Psychiatry"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1152\/jn.01199.2005","article-title":"Specific subtypes of GABAA receptors mediate phasic and tonic forms of inhibition in hippocampal pyramidal neurons","volume":"96","author":"GA Prenosil","year":"2006","journal-title":"Journal of Neurophysiology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrn2807","article-title":"Modeling the molecular mechanisms of synaptic plasticity using systems biology approaches","volume":"11","author":"JH Kotaleski","year":"2010","journal-title":"Nature Reviews Neuroscience"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1152\/physrev.00014.2003","article-title":"Long-term potentiation and memory","volume":"84","author":"MA Lynch","year":"2004","journal-title":"Physiology Reviews"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ceca.2005.06.013","article-title":"Ca2+ and synaptic plasticity","volume":"38","author":"M Cavazzini","year":"2005","journal-title":"Cell Calcium"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"10831","DOI":"10.1073\/pnas.152343099","article-title":"A unified model of NMDA receptor-dependent bidirectional synaptic plasticity","volume":"99","author":"HZ Shouval","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nrn2774","article-title":"Abnormal neural oscillations and synchrony in schizophrenia","volume":"11","author":"PJ Uhlhaas","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nrn1993","article-title":"Intermediate phenotypes and genetic mechanisms of psychiatric disorders","volume":"7","author":"A Meyer-Lindenberg","year":"2006","journal-title":"Nature Reviews Neuroscience"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1152\/jn.00870.2007","article-title":"Modeling GABA alterations in schizophrenia: a link between impaired inhibition and altered gamma and beta range auditory entrainment","volume":"99","author":"D Vierling-Claassen","year":"2008","journal-title":"Journal of Neurophysiology"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/S1388-2457(00)00425-9","article-title":"MEG gamma band activity in schizophrenia patients and healthy subjects in a mental arithmetic task and at rest","volume":"111","author":"J Kissler","year":"2000","journal-title":"Clinical Neurophysiology"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0006-3223(02)01360-4","article-title":"Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins","volume":"52","author":"CL Beasley","year":"2002","journal-title":"Biological Psychiatry"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1176\/appi.ajp.2007.07081223","article-title":"Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia","volume":"165","author":"T Hashimoto","year":"2008","journal-title":"American Journal of Psychiatry"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/sj.mp.4001471","article-title":"Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium","volume":"9","author":"MB Knable","year":"2004","journal-title":"Molecular Psychiatry"},{"key":"ref59","first-page":"173","article-title":"Workshop on statistical approaches for the evaluation of complex computer models","volume":"17","author":"R Berk","year":"2007","journal-title":"Statistical Science"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1214\/009053607000000163","article-title":"Computer model validation with functional output","volume":"35","author":"M Bayarri","year":"2007","journal-title":"The Annals of Statistics"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Easterling R, Berger J. Statistical foundations for the validation of computer models. In: Pace D, Stevenson S, editors; 2002. Society for Modeling and Simulation International.","DOI":"10.2172\/809985"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2125.1984.tb02387.x","article-title":"Plasma concentrations of unbound phenytoin in the management of epilepsy","volume":"17","author":"CJ Kilpatrick","year":"1984","journal-title":"British Journal of Clinical Pharmacology"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0022-3565(24)37226-X","article-title":"Reduction of Cortical Pyramidal Neuron Excitability by the Action of Phenytoin on Persistent Na+ Current","volume":"284","author":"I Lampl","year":"1998","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00007691-197901000-00010","article-title":"Phenytoin: EEG effects and plasma levels in volunteers","volume":"1","author":"M Fink","year":"1979","journal-title":"Therapeutic Drug Monitoring"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1097\/00001756-199509000-00017","article-title":"Effects of phenytoin on the persistent Na+ curent of mammalian CNS neurons","volume":"6","author":"TI Chao","year":"1995","journal-title":"NeuroReport"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00004691-199304000-00008","article-title":"Effects of antiepileptic drug treatment on the background frequency of EEGs in epileptic patients","volume":"10","author":"GK Herkes","year":"1993","journal-title":"Journal of Clinical Neurophysiology"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000118570","article-title":"Comparison of the effects of lamotragine and phenytoin on the EEG power spectrum and cortical brainstem-evoked responses of normal human volunteers","volume":"21","author":"A Van Wieringen","year":"1989","journal-title":"Neuropsychobiology"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"7152","DOI":"10.1073\/pnas.0402060101","article-title":"A role for fast rhythmic bursting neurons in cortical gamma oscillations in vitro","volume":"101","author":"MO Cunningham","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0014-2999(86)90799-5","article-title":"Effects of nimodipine on EEG and 31P-NMR spectra during and after incomplete forebrian ischemia in the rat","volume":"125","author":"NEP Deutz","year":"1986","journal-title":"European Journal of Pharmacology"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1046\/j.1472-8206.2002.00110.x","article-title":"Effects of nicardipine and clonidine on cognitive functions and electroencephalography in hypertensive patients","volume":"16","author":"T Denolle","year":"2002","journal-title":"Fundamental and Clinical Pharmacology"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000026614","article-title":"Plasma concentrations and CNS effects of Ca antagonists darodpine and nimodipine after single-dose oral administration to healthy volunteers","volume":"40","author":"WG Sannita","year":"1999","journal-title":"Neuropsychobiolgy"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0026-895X(25)10553-1","article-title":"Interactions among GYKI-52488, cyclothiazide, and anifacetam at recombinant AMPA and kainate receptors","volume":"48","author":"TH Johansen","year":"1995","journal-title":"Molecular Pharmacology"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1124\/mol.58.4.802","article-title":"Effects of the potent amapkine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466","volume":"58","author":"AC Arai","year":"2000","journal-title":"Molecular Pharmacology"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1124\/jpet.102.040360","article-title":"Benzamide-type AMPA receptor modulators form two subfamilies with distinct modes of action","volume":"303","author":"AC Arai","year":"2002","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1021\/jm1000419","article-title":"Positive allosteric modulators of the alpha-amino-3-hyroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor","volume":"53","author":"SJA Grove","year":"2010","journal-title":"Journal of Medicinal Chemistry"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.npp.1301444","article-title":"A placebo-controlled add-on trial of amapkine, CX516, for cognitive deficits in schizophrenia","volume":"33","author":"DC Goff","year":"2008","journal-title":"Neuropsychopharmacology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0058607","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T01:04:48Z","timestamp":1745975088000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0058607"}},"subtitle":[],"editor":[{"given":"Allan V.","family":"Kalueff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,19]]},"references-count":76,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0058607","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,19]]}}}